The funding round was backed by Mercia, the MEIF Proof of Concept and Early Stage Fund, the Angel Co-Fund, and private investors.
"The world of work has never been more complex, so it is important that organisations make decisions based on accurate data. At HR Datahub our mission is to give them the analysis and the insights they need. The funding will enable us to add a new level of sophistication to the platform and roll it out to an even wider audience."
Mercia backed the London enterprise with a £3.3m investment to support growth and hiring.
"Global expansion is complex, with confusing local laws, complicated taxes and hefty fines for those who fail to play by the rules. Centuro cuts through the complexity, eradicating the need for expensive consultancy services. We’re disrupting the dominance of the larger players in the market, giving ambitious businesses a simple solution that saves them time and money, reduces compliance risks and helps them win in new markets and in the war for global talent."
The funding round was led by Mercia with backing from Beringea to support private sector expansion and new academy launches.
"These are really exciting times for our business and we are delighted that Mercia have invested in us alongside Beringea to help us scale and support more organisations to deliver a positive contribution to society and the planet. Their investment will allow us to continue to improve and innovate, making it easier for members provide to more social good."
The London based mobile advertising platform has picked up further backing from Mercia to support its international growth.
"At a time when privacy regulation is increasingly limiting the use of personal data, our sophisticated and unique combination of creative, media and AI is leading brand performance on mobile. With this additional investment from Mercia, the next stage of our AI-led platform, offering fully automated capabilities, will provide brands and agencies the chance to translate user attention into profit."
The Yorkshire-based medical technology company secured backing from Mercia and private investors to support production and international expansion.
"The Eventum team have done a massive amount of work in a short space of time in developing Quadsense and getting it approved for clinical use. We are now excited to start scaling up the team to commercialise the product, as well as bringing further innovations to the orthopaedics market."